Watch Desk posted an update
UK healthtech company Nayara has closed a pre-seed funding round led by SFC Capital to develop and expand its AI platform for supporting patients between clinical appointments. The platform is designed to answer routine questions, check in with patients and flag concerns for healthcare teams.
Why it mattersTech.eu reports that Nayara’s AI companion for breast cancer patients has supported hundreds of people. The new funding is intended to support product development, clinical validation and commercial expansion. Helpful support between appointments is a worthwhile ambition; in healthcare, the evidence that it works matters just as much.
Discuss: What should a company have to show before an AI patient companion is used more widely: clinical validation, patient outcomes, or both?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.
Your turn
Pull up a chair.
Write first. We’ll sort the introductions when you submit.